Breathing life into new markets
More and more, life sciences organizations are exploring the benefits of mergers and acquisitions (M&A). Whether they’re looking to grow their portfolio of existing products or expand operations to new markets overseas, BDO can help your organization successfully navigate these complex and multi-faceted transactions and bring you peace of mind with your financial reporting.
From understanding the complexities of research and development tax credits and Health Canada and FDA regulations to licensing agreements and due diligence, we guide pharmaceutical, biotech, and medical device manufacturers at every stage of development. We also advise clients on how best to access capital, identify value-add opportunities, and structure tax-efficient operations.
Featured insights and offerings for the life sciences industry
Resources to support your business
Scientific research and experimental development (SR&ED)
When you are trying to develop or improve your business's products or processes, the Canadian scientific research and experimental development (SR&ED) federal tax program could be beneficial. Did you know SR&ED activities go beyond those occurring in the lab?
Learn moreBusiness stages for the life sciences industry
Growth strategies designed to match your business model, your goals, and your expectations.
Grow, expand & acquireSeamlessly transition your enterprise through three critical stages: succession planning, valuation optimization, and a strategic transaction.
Exit, transition & sell